搜索临床试验以:吡咯替尼加曲妥珠单抗和多西紫杉醇和卡铂
总计9189个结果
-
Shandong Cancer Hospital and Institute未知转移性乳腺癌 | HER2阳性乳腺癌
-
Fujian Medical University Union Hospital招聘中
-
Shanghai Institute Of Biological ProductsFudan University完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Fudan University招聘中
-
European Organisation for Research and Treatment...GlaxoSmithKline完全的
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; Cephalon完全的
-
Shanghai Jiao Tong University School of MedicineShanghai 10th People's Hospital; Jiangxi Provincial Cancer Hospital; Shanghai Tongji Hospital,... 和其他合作者招聘中
-
Sun Yat-sen University招聘中
-
Jiangsu HengRui Medicine Co., Ltd.招聘中非鳞状非小细胞肺癌 | HER2 外显子 20 突变大韩民国, 美国, 台湾, 比利时, 西班牙, 中国, 澳大利亚, 火鸡, 意大利, 法国, 德国, 波兰, 俄罗斯联邦
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)完全的
-
Guangdong Provincial People's Hospital尚未招聘HER2 阳性、ER 阳性乳腺癌的新辅助治疗
-
First Affiliated Hospital of Zhejiang University招聘中
-
Guangdong Provincial People's Hospital招聘中
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Pulmonary Hospital, Shanghai, China终止
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.主动,不招人
-
Miguel Martín JiménezUNC Lineberger Comprehensive Cancer Center; Hospital Universitario Ramon y Cajal; Centro Nacional... 和其他合作者主动,不招人
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Herbert Irving Comprehensive Cancer Center未知卵巢癌 | 输卵管癌 | 子宫内膜癌 | 原发性腹膜腔癌美国
-
Hope Cancer Institute, Inc.未知
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Intergroupe Francophone de Cancerologie Thoracique完全的
-
University College London Hospitals完全的乳腺癌 | 遗传性乳腺癌/卵巢癌(brca1、brca2) | brca1突变携带者 | brca2突变携带者澳大利亚, 以色列, 英国, 西班牙, 瑞典, 葡萄牙
-
King Faisal Specialist Hospital & Research Center完全的
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)终止